|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University Health Network, Toronto |
| Information provided by: | University Health Network, Toronto |
| ClinicalTrials.gov Identifier: | NCT00602992 |
Purpose
Gamma Knife radiosurgery is a non-invasive technique for the delivery of a single, high dose of radiation to an intra-cranial target. MRI has an established and central role in the treatment planning process and assessment of response to intracranial radiosurgery. Increasing the field strength of MRI from 1.5T to 3T promises to improve the signal, and in turn the quality of images. However, the technology also introduces new limitations, and the role and safety of 3T MRI in the management of patients receiving radiosurgery has not yet been reported. In this pilot study, we will explore the spatial integrity, and incremental image-guidance utility of 3T MRI in patients receiving radiosurgery. The preliminary data acquired in this study will be instrumental to the judicious design and conduct of subsequent definitive clinical trials. Up to fifty patients will be enrolled in this study.
| Condition |
|
Trigeminal Neuralgia Acoustic Neuroma Brain Metastases |
| Genetics Home Reference related topics: | neurofibromatosis type 2 |
| MedlinePlus related topics: | Trigeminal Neuralgia |
| Study Type: | Observational |
| Study Design: | Cohort, Cross-Sectional |
| Official Title: | Exploring the Role of 3T MRI in Gamma Knife Radiosurgery: A Pilot Study |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients who have consented to Gamma Knife radiosurgery.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Heather A Sharpe, B.Sc. | 416-946-4501 ext 3427 | heather.sharpe@uhn.on.ca |
| Canada, Ontario | |||||
| Toronto Western Hospital | Recruiting | ||||
| Toronto, Ontario, Canada, M5T 2S8 | |||||
| Contact: Heather Sharpe, B. Sc. 416-946-4501 ext 3427 heather.sharpe@uhn.on.ca | |||||
| Principal Investigator: Cynthia Menard, MD | |||||
| University Health Network, Toronto |
| Principal Investigator: | Cynthia Menard, MD | University Health Network, Toronto |
More Information
| Responsible Party: | University Health Network ( Dr. Cynthia Menard ) |
| Study ID Numbers: | 06-0427-CE |
| First Received: | September 19, 2007 |
| Last Updated: | January 26, 2008 |
| ClinicalTrials.gov Identifier: | NCT00602992 |
| Health Authority: | Canada: Health Canada |
|
|
|
|
|